Fresenius Medical Care

Fresenius Medical Care AG & Co. KgaA provides products and services for individuals with renal diseases. The firm develops and manufactures health care products, which includes dialysis and non-dialysis products. It operates through the following segments: North America Segment, EMEA Segment, Asia-Pacific Segment and Latin America Segment. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius SE & Co. KGaA (FSNUF) Management on Q2 2020 Results - Earnings Call Transcript

Fresenius Medical Care AG & Co. KGaA (FMS) CEO Robert Powell on Q2 2020 Results - Earnings Call Transcript

LAKE ZURICH, Ill.--(BUSINESS WIRE)--The date under the "Expiration Date" column for the row associated with Batch Number 6122207 should read: 06/2021 (instead of 06/2020).

CORRECTING and REPLACING Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial.

Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine

ABIOMED

FMS vs. ABMD: Which Stock Is the Better Value Option?

FMS vs. ABMD: Which Stock Should Value Investors Buy Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy FRESENIUS SECO (FSNUY) Stock?

Bank of Nova Scotia

British American Tobacco

Canadian Imperial Bank of Commerce

Canadian Natural Resources

Chevron

Con Ed

Enbridge

L'Oreal SA

Micro Focus International PLC

Prudential Financial

Royal Bank of Canada

Suncor Energy

AT&T

WPP Plc Sponsored

Exxon Mobil

Kiplinger Investing, offering "insights for investors" online, compiled a "Worlds Most Reliable" list of 99 in October, 2018. Data updated 6/25/20 showed 19 whose yields signaled a time to buy.

Kiplinger's 'Most Reliable Dividend Stocks On Earth' Shows 16 Buys For July

Arena Pharmaceuticals

Cara Therapeutics

These companies are all surprising a few doubters lately.

3 Pot Stocks Worth a Second Look

Medtronic

LeMaitre Vascular

MSA Safety

MSA Safety, Fresnius Medical Care, and LeMaitre Vascular are well-priced stocks on the rise with solid dividends.

3 Medical-Supply Stocks You Should Own Besides Medtronic

Fresenius Medical's (FMS) first-quarter earnings benefit from strong segmental performance.

Fresenius Medical (FMS) Q1 Earnings Miss Estimates, Fall Y/Y

Fresenius' (FSNUF) Management on Q1 2020 Results - Earnings Call Transcript

Fresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q1 2020 Results - Earnings Call Transcript

STAMFORD, Conn. and ST. GALLEN, Switzerland, April  21, 2020  (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA) and Vifor Fresenius Medical Care Renal Pharma (VFMCRP), today announced positive topline data from Cara’s KALM-2 pivotal Phase 3 trial of KORSUVA™ (CR845/difelikefalin) Injection in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP).

Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma Announce Positive Results From Global KALM-2 Pivotal Phase 3 Trial of KORSUVATM Injection in Hemodialysis Patients with Pruritus

Fresenius: A Strong Buy After A 65% Sell-Off

Fresenius SE presented solid full-year results and is getting more optimistic about the mid-term future.

Fresenius SE: A Good Buying Opportunity

Fresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q4 2019 Results - Earnings Call Transcript

Germany's Fresenius Medical Care  on Wednesday said quarterly adjusted operating income edged 3% higher as growth in dialysis services and products was partly offset by a negative adjustment for accounts receivable in a legal dispute in North America.

Fresenius Medical says fourth-quarter operating profit up 3%

Let's see if Fresenius Medical (FMS) stock is a good choice for value-oriented investors right now from multiple angles.

Should Value Investors Pick Fresenius Medical (FMS) Stock?

These two companies could be headed in vastly different directions in 2020.

Better Buy: Cara Therapeutics vs. Fresenius

Fresenius (FMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Fresenius (FMS) Upgraded to Buy: Here's What You Should Know

Toronto-Dominion Bank

These value stocks could become popular options for investors if a correction in the markets takes place.

2 Bargain Stocks You Can Buy Today: FMS & TD

Brookdale Senior Living

Cigna

Encompass Health

HCA Healthcare

Healthcare Services Group

MEDNAX

The doctor is ordering you to protect your portfolio by avoiding these seven healthcare stocks. There are better investments elsewhere.

7 Sickly Healthcare Stocks to Avoid

Deutsche Post AG

SAP SE

Siemens AG

The German Dividend Aristocrats (GDA) have been updated - this is the 2019 version.

German Dividend Aristocrats - The 2019 Update

Fresenius Medical's (FMS) Q3 earnings benefit from strong segmental performance and solid 2019 EPS outlook.

Fresenius Medical (FMS) Q3 Earnings & Revenues Top Estimates

Fresenius SE & Co. KGaA's (FSNUF) CEO Stephan Sturm on Q3 2019 Results - Earnings Call Transcript

News for Fresenius Medical Care Stock (FMS)